🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alen Ostojić

University Hospital Centre Zagreb

ORCID: 0000-0001-8324-2176

Also affiliated with AstraZeneca (Singapore), National Cancer Institute, Center for Cancer Research

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention”.

High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention

Blood Advances(2024)10.1182/bloodadvances.2023010973
N/A
0.451DataRank · unranked
11 citations

Lauren M. Curtis, Rachel B. Salit, Brian C. Shaffer, Filip Pirsl, Alen Ostojić +14 more

Clinical characteristics and cytokine biomarkers in patients with chronic graft‐vs‐host disease persisting seven or more years after diagnosis

American Journal of Hematology(2020)10.1002/ajh.25717
N/A
0DataRank · unranked
13 citations

Annie Im, Liang Cao, Filip Pirsl, Seth M. Steinberg, Lauren M. Curtis +10 more

Subsequent Cancers in Patients Affected with Moderate or Severe Chronic Graft-versus-Host Disease

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.08.001
N/A
0DataRank · unranked
10 citations

Filip Pirsl, Noa G. Holtzman, Seth M. Steinberg, Jeannette Nashed, Claire Ruben +10 more

Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease

Bone Marrow Transplantation(2021)10.1038/s41409-021-01419-2
N/A
0DataRank · unranked
7 citations

Leorey N. Saligan, Filip Pirsl, Noa G. Holtzman, Alen Ostojić, Seth M. Steinberg +9 more